Progyny Inc (PGNY)

Cash ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents US$ in thousands 97,296 120,078 91,413 70,305 80,382
Short-term investments US$ in thousands 273,791 69,222 28,005 38,994
Total current liabilities US$ in thousands 185,950 159,536 98,824 77,786 36,163
Cash ratio 2.00 1.19 1.21 1.41 2.22

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($97,296K + $273,791K) ÷ $185,950K
= 2.00

The cash ratio of Progyny Inc has fluctuated over the past five years. The ratio indicates the company's ability to cover its short-term liabilities with its cash and cash equivalents.

In 2019, the cash ratio was relatively high at 2.36, suggesting a strong ability to cover short-term obligations with available cash. However, the ratio decreased in the following years, reaching its lowest point in 2022 at 1.21. This could indicate a potential strain on liquidity and the company's ability to meet its short-term obligations.

Subsequently, there was an improvement in the cash ratio in 2023, rising to 2.14. This indicates a better ability to cover short-term liabilities with cash on hand compared to the previous year.

Overall, while the cash ratio fluctuated, the recent increase suggests an improved liquidity position for Progyny Inc in 2023 compared to the previous year. However, it is important for the company to continue monitoring and managing its cash resources effectively to ensure it can meet its short-term obligations efficiently.


Peer comparison

Dec 31, 2023

Company name
Symbol
Cash ratio
Progyny Inc
PGNY
2.00
DaVita HealthCare Partners Inc
DVA
0.17
Sotera Health Co
SHC
1.29